Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,385 | 1,725 | 669 | 0 | 0 |
| Receivables | 259 | 142 | 175 | 0 | 0 |
| Other current assets | 0 | 0 | 2 | 0 | 0 |
| TOTAL | $4,166 | $1,990 | $886 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 150 | 160 | 68 | N/A | N/A |
| Intangibles | 4,559 | 4,640 | 4,703 | 0 | 0 |
| Other Non-Current Assets | 37 | 36 | 36 | 0 | 0 |
| TOTAL | $4,746 | $4,837 | $4,807 | $N/A | $N/A |
| Total Assets | $8,912 | $6,826 | $5,693 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 250 | 0 | 0 |
| Accounts payable and accrued liabilities | 35 | 68 | 72 | 0 | 0 |
| Accrued Expenses | 1,902 | 1,342 | 1,888 | 0 | 0 |
| Other current liabilities | N/A | 240 | N/A | 0 | 0 |
| TOTAL | $1,936 | $1,651 | $2,291 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,936 | $1,651 | $2,291 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5 | 5 | 5 | N/A | N/A |
| Common Shares | 15 | 13 | 12 | 0 | 0 |
| Retained earnings | -11,673 | -9,732 | -8,026 | 0 | 0 |
| TOTAL | $6,976 | $5,176 | $3,402 | $0 | $0 |
| Total Liabilities And Equity | $8,912 | $6,826 | $5,693 | $0 | $0 |